Neurocrine Biosciences Market Cap

Neurocrine Biosciences has a market cap or net worth of $12.03 billion as of February 21, 2025. Its market cap has decreased by -13.54% in one year.

Market Cap

12.03B

Enterprise Value

11.45B

1-Year Change

-13.54%

Ranking

#784

Market Cap Chart

Since December 1, 1998, Neurocrine Biosciences's market cap has increased from $124.10M to $12.03B, an increase of 9,596.39%. That is a compound annual growth rate of 19.04%.

Market Cap History

Date	Market Cap	% Change
Feb 20, 2025	11.58B	-16.23%
Dec 31, 2024	13.82B	6.76%
Dec 29, 2023	12.95B	12.74%
Dec 30, 2022	11.48B	42.11%
Dec 31, 2021	8.08B	-9.78%
Dec 31, 2020	8.96B	-9.54%
Dec 31, 2019	9.90B	52.87%
Dec 31, 2018	6.48B	-5.69%
Dec 29, 2017	6.87B	104.24%
Dec 30, 2016	3.36B	-31.05%
Dec 31, 2015	4.88B	187.17%
Dec 31, 2014	1.70B	169.95%
Dec 31, 2013	629.00M	26.66%
Dec 31, 2012	496.60M	5.73%
Dec 30, 2011	469.70M	12.07%
Dec 31, 2010	419.10M	293.15%
Dec 31, 2009	106.60M	-13.68%
Dec 31, 2008	123.50M	-28.41%
Dec 31, 2007	172.50M	-56.31%
Dec 29, 2006	394.80M	-82.96%
Dec 30, 2005	2.32B	28.86%
Dec 31, 2004	1.80B	-6.54%
Dec 31, 2003	1.92B	37.67%
Dec 31, 2002	1.40B	3.88%
Dec 31, 2001	1.35B	84.02%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	784.71B
UnitedHealth Group	429.24B
Novo Nordisk	391.83B
Johnson & Johnson	390.76B
AbbVie	356.74B
Abbott Laboratories	234.01B
AstraZeneca	229.50B
Merck & Co.	226.40B

Market Cap Rankings